Hepatitis B, vaccination and healthcare workers

Occupational Medicine

Volumn 50, Issue 6, 2000, Pages 383-386

  Murphy, E ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Healthcare workers; Hepatitis B; Vaccination

Indexed keywords

DNA VACCINE; HEPATITIS B VACCINE; RECOMBINANT VACCINE; VIRUS DNA;

GENE MUTATION; HEALTH CARE PERSONNEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; NONHUMAN; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS HEPATITIS; VIRUS TRANSMISSION;

EID: 0033842320     PISSN: 09627480     EISSN: None     Source Type: Journal    
DOI: 10.1093/occmed/50.6.383     Document Type: Review

References (46)

1. Clinical interactions between human immunodeficiency virus and human hepatitis viruses
2. Needlestick and sharps injuries among healthcare workers in Taiwan
3. Integration of hepatitis B vaccination into national immunisation programmes
4. Fatal outcome of transmission of hepatitis B from an e antigen negative surgeon
5. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen
6. Quarterly Communicable Disease Review July to September 1998 From the PHLS Communicable Disease Surveillance Centre
7. Acute hepatitis B infection associated with blood transfusion in England and Wales 1991-7. Review of database
8. The prevalence of hepatitis B infection in adults in England and Wales
9. Ten-year follow up study of hepatitis B virus infection and vaccination status of hospital employees
10. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study
11. Provider to patient transmission of hepatitis B virus
12. Ethics of transmission of hepatitis B virus by health care workers
13. Hepatitis B virus DNA in relation to duration of hepatitis B surface antigen carriage
14. A fifth of e antigen negative carriers of hepatitis B virus should not perform exposure prone procedures
15. Surgeon had mutant form of hepatitis B
16. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination
17. Imunogenicity of recombinant hepatitis B vaccine in adults
18. Long-term persistence of anti HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8 Year results
19. Vaccine induced immunological memory for hepatitis B surface antigen implications for policy on booster vaccination
20. Longterm immunogenicity and efficacy of hepatitis B vaccine in homosexual men
21. The mathematical model predicting anti hepatitis B virus surface antigen anti HBs decay after vaccination against hepatitis B
22. Implementation of Department of Health guidelines for hepatitis B vaccination: A regional audit of NHS occupational health policies and procedures
23. Antibody titres to hepatitis B surface antigen among vaccinated emergency physicians Three years experience with a wellness booth
24. Occupational injuries and infection control
25. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine
26. Hepatitis B vaccination in persons with isolated hepatitis B care antibodies
27. Hepatitis B vaccination in hospital personnel and medical students
28. Hepatitis B immunisation in health care workers dealing with vaccine non-response
29. Non-response to hepatitis B vaccination: What next?
30. Comparative trial of standard or high dose S sub-unit recombinant hepatitis B vaccine versus a vaccine containing S sub-unit, pre-S1 and pre-S2 particles for revaccination of healthy adult non-responders
31. Immune response to a new hepatitis B vaccine in health-care workers who had not responded to standard vaccine: Randomised double blind dose response study
32. Hepatitis B. Are you protected?
33. Host factors related to poor immunogenicity of hepatitis B vaccine in adults. Another reason to immunise early
34. Parameters potentially affecting interpretation of immunogenicity and efficacy data in vaccine trials: Are they adequately reported
35. Randomized comparison of 5 and 10 μg doses of two recombinant hepatitis B vaccines
36. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose
37. The first combined vaccine against hepatitis A and B: An overview
38. Hepatitis B vaccines. Why does doing good have its opponents?
39. Multiple sclerosis and hepatitis B vaccine
40. Update on recommendations for post vaccination testing and boosters after hepatitis B vaccination
41. Hepatitis B virus infection in hospital staff: Epidemiology and persistence of vaccine induced antibodies
42. Adult immunisations: Recommendations